{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:26:02Z","timestamp":1749939962412,"version":"3.37.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175045"],"award-info":[{"award-number":["175045"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00213-020-05470-7","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T06:02:42Z","timestamp":1580882562000},"page":"1435-1446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Eslicarbazepine acetate interacts in a beneficial manner with standard and alternative analgesics to reduce trigeminal nociception"],"prefix":"10.1007","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-5978","authenticated-orcid":false,"given":"Uro\u0161","family":"Pecikoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Tomi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Micov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milja","family":"Vukovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radica","family":"Stepanovi\u0107-Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"5470_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pain.2005.03.008","volume":"115","author":"AH Ahn","year":"2005","unstructured":"Ahn AH, Basbaum AI (2005) Where do triptans act in the treatment of migraine? Pain 115:1\u20134. https:\/\/doi.org\/10.1016\/j.pain.2005.03.008","journal-title":"Pain"},{"key":"5470_CR2","doi-asserted-by":"publisher","first-page":"14869","DOI":"10.1523\/JNEUROSCI.0943-13.2013","volume":"33","author":"S Akerman","year":"2013","unstructured":"Akerman S, Holland PR, Lasalandra MP, Goadsby PJ (2013) Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and \u201ctriptan\u201d receptors: implications in migraine. J Neurosci 33:14869\u201314877. https:\/\/doi.org\/10.1523\/JNEUROSCI.0943-13.2013","journal-title":"J Neurosci"},{"key":"5470_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1472-8206.2008.00617.x","volume":"22","author":"G Alves","year":"2008","unstructured":"Alves G, Figueiredo I, Castel-Branco M, Louren\u00e7o N, Falc\u00e3o A, Caramona M, Soares-da-Silva P (2008) Disposition of eslicarbazepine acetate in the mouse after oral administration. Fundam Clin Pharmacol 22:529\u2013536. https:\/\/doi.org\/10.1111\/j.1472-8206.2008.00617.x","journal-title":"Fundam Clin Pharmacol"},{"key":"5470_CR4","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/BF00965147","volume":"19","author":"MH Baf","year":"1994","unstructured":"Baf MH, Subhash MN, Lakshmana KM, Rao BS (1994) Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine. Neurochem Res 19:1139\u20131143. https:\/\/doi.org\/10.1007\/BF00965147","journal-title":"Neurochem Res"},{"key":"5470_CR5","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/j.1468-1331.2010.03070.x","volume":"17","author":"L Bendtsen","year":"2010","unstructured":"Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J, EFNS (2010) EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol 17:1318\u20131325. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03070.x","journal-title":"Eur J Neurol"},{"issue":"Suppl 4","key":"5470_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2165\/00003495-198600324-00006","volume":"32","author":"RN Brogden","year":"1986","unstructured":"Brogden RN (1986) Pyrazolone derivatives. Drugs 32(Suppl 4):60\u201370. https:\/\/doi.org\/10.2165\/00003495-198600324-00006","journal-title":"Drugs"},{"key":"5470_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/JPR.S75160","volume":"8","author":"K Brune","year":"2015","unstructured":"Brune K, Patrignani P (2015) New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res 8:105\u2013118. https:\/\/doi.org\/10.2147\/JPR.S75160","journal-title":"J Pain Res"},{"key":"5470_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.bjp.0705724","volume":"141","author":"JG Chichorro","year":"2004","unstructured":"Chichorro JG, Lorenzetti BB, Zampronio AR (2004) Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats. Br J Pharmacol 141:1175\u20131184. https:\/\/doi.org\/10.1038\/sj.bjp.0705724","journal-title":"Br J Pharmacol"},{"key":"5470_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/0333102417704187","volume":"37","author":"JG Chichorro","year":"2017","unstructured":"Chichorro JG, Porreca F, Sessle B (2017) Mechanisms of craniofacial pain. Cephalalgia 37:613\u2013626. https:\/\/doi.org\/10.1177\/0333102417704187","journal-title":"Cephalalgia"},{"key":"5470_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neulet.2003.08.065","volume":"352","author":"HS Choi","year":"2003","unstructured":"Choi HS, Lee HJ, Jung CY, Ju JS, Park JS, Ahn DK (2003) Central cyclooxygenase-2 participates in interleukin-1 beta-induced hyperalgesia in the orofacial formalin test of freely moving rats. Neurosci Lett 352:187\u2013190. https:\/\/doi.org\/10.1016\/j.neulet.2003.08.065","journal-title":"Neurosci Lett"},{"key":"5470_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2005.07.049","volume":"390","author":"R Clinckers","year":"2005","unstructured":"Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y (2005) Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine. Neurosci Lett 390:48\u201353. https:\/\/doi.org\/10.1016\/j.neulet.2005.07.049","journal-title":"Neurosci Lett"},{"key":"5470_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1468-2982.2004.00694.x","volume":"24","author":"DW Dodick","year":"2004","unstructured":"Dodick DW, Martin V (2004) Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms. Cephalalgia 24:417\u2013424. https:\/\/doi.org\/10.1111\/j.1468-2982.2004.00694.x","journal-title":"Cephalalgia"},{"key":"5470_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3906\/sag-1601-195","volume":"47","author":"H Do\u011fanay Aydin","year":"2017","unstructured":"Do\u011fanay Aydin H, Vuralli D, Ak\u00e7ali DT, Bolay H (2017) Metoclopramide inhibits trigeminovascular activation: evidence for effective acute attack treatment in migraine. Turk J Med Sci 47:343\u2013347. https:\/\/doi.org\/10.3906\/sag-1601-195","journal-title":"Turk J Med Sci"},{"key":"5470_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/j.1532-2149.2011.00057.x","volume":"16","author":"W Escobar","year":"2012","unstructured":"Escobar W, Ramirez K, Avila C, Limongi R, Vanegas H, Vazquez E (2012) Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats. Eur J Pain 16:676\u2013689. https:\/\/doi.org\/10.1002\/j.1532-2149.2011.00057.x","journal-title":"Eur J Pain"},{"key":"5470_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","volume":"16","author":"S Evers","year":"2009","unstructured":"Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, S\u00e1ndor PS, European Federation of Neurological Societies (2009) EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol 16:968\u2013981. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02748.x","journal-title":"Eur J Neurol"},{"key":"5470_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1476-5381.1984.tb16512.x","volume":"83","author":"FW Foong","year":"1984","unstructured":"Foong FW, Satoh M (1984) The periaqueductal gray is the site of the antinociceptive action of carbamazepine as related to bradykinin-induced trigeminal pain. Br J Pharmacol 83:493\u2013497. https:\/\/doi.org\/10.1111\/j.1476-5381.1984.tb16512.x","journal-title":"Br J Pharmacol"},{"key":"5470_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0014-4886(85)90059-7","volume":"90","author":"FW Foong","year":"1985","unstructured":"Foong FW, Satoh M (1985) Antinociceptive effect of intracisternal carbamazepine evidenced by the bradykinin-induced biting-like response in rats. Exp Neurol 90:264\u2013267. https:\/\/doi.org\/10.1016\/0014-4886(85)90059-7","journal-title":"Exp Neurol"},{"key":"5470_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.eplepsyres.2013.08.013","volume":"107","author":"A Fortuna","year":"2013","unstructured":"Fortuna A, Alves G, Soares-da-Silva P, Falc\u00e3o A (2013) Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models. Epilepsy Res 107:37\u201350. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.08.013","journal-title":"Epilepsy Res"},{"key":"5470_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ar.21078","volume":"293","author":"Y Gao","year":"2010","unstructured":"Gao Y, Duan YZ (2010) Increased COX2 in the trigeminal nucleus caudalis is involved in orofacial pain induced by experimental tooth movement. Anat Rec (Hoboken) 293:485\u2013491. https:\/\/doi.org\/10.1002\/ar.21078","journal-title":"Anat Rec (Hoboken)"},{"key":"5470_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1055\/s-0034-1398550","volume":"65","author":"A Gencer","year":"2015","unstructured":"Gencer A, Gunduz O, Ulugol A (2015) Involvement of descending serotonergic and noradrenergic systems and their spinal receptor subtypes in the antinociceptive effect of dipyrone. Drug Res (Stuttg) 65:645\u2013649. https:\/\/doi.org\/10.1055\/s-0034-1398550","journal-title":"Drug Res (Stuttg)"},{"key":"5470_CR21","first-page":"803","volume-title":"Wall and Melzack's textbook of pain","author":"JL Gibbs","year":"2013","unstructured":"Gibbs JL, Hargreaves KM (2013) Acute and chronic orofacial and dental pain. In: McMahon SB, Koltzenburg M, Tracey I, Turk DC (eds) Wall and Melzack's textbook of pain, 6th edn. Elsevier Saunders, Philadelphia, pp 803\u2013814","edition":"6"},{"key":"5470_CR22","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S1474-4422(13)70193-5","volume":"12","author":"I Gilron","year":"2013","unstructured":"Gilron I, Jensen TS, Dickenson AH (2013) Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol 12:1084\u20131095. https:\/\/doi.org\/10.1016\/S1474-4422(13)70193-5","journal-title":"Lancet Neurol"},{"key":"5470_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","volume":"21","author":"GG Graham","year":"2013","unstructured":"Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF (2013) The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology 21:201\u2013232. https:\/\/doi.org\/10.1007\/s10787-013-0172-x","journal-title":"Inflammopharmacology"},{"key":"5470_CR24","first-page":"129","volume-title":"Wall and Melzack's textbook of pain","author":"MM Heinricher","year":"2013","unstructured":"Heinricher MM, Fields HL (2013) Central nervous system mechanisms of pain modulation. In: McMahon SB, Koltzenburg M, Tracey I, Turk DC (eds) Wall and Melzack's textbook of pain, 6th edn. Elsevier Saunders, Philadelphia, pp 129\u2013142","edition":"6"},{"key":"5470_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11940-012-0205-6","volume":"15","author":"LA Hershey","year":"2013","unstructured":"Hershey LA, Bednarczyk EM (2013) Treatment of headache in the elderly. Curr Treat Options Neurol 15:56\u201362. https:\/\/doi.org\/10.1007\/s11940-012-0205-6","journal-title":"Curr Treat Options Neurol"},{"key":"5470_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1744-8069-4-54","volume":"4","author":"HJ Jeong","year":"2008","unstructured":"Jeong HJ, Chenu D, Johnson EE, Connor M, Vaughan CW (2008) Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain 4:54. https:\/\/doi.org\/10.1186\/1744-8069-4-54","journal-title":"Mol Pain"},{"key":"5470_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1523\/JNEUROSCI.1945-17.2017","volume":"38","author":"PP Klinger-Gratz","year":"2018","unstructured":"Klinger-Gratz PP, Ralvenius WT, Neumann E, Kato A, Nyilas R, Lele Z, Katona I, Zeilhofer HU (2018) Acetaminophen relieves inflammatory pain through CB1 cannabinoid receptors in the rostral ventromedial medulla. J Neurosci 38:322\u2013334. https:\/\/doi.org\/10.1523\/JNEUROSCI.1945-17.2017","journal-title":"J Neurosci"},{"key":"5470_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/papr.12467","volume":"17","author":"J Konijnenbelt-Peters","year":"2017","unstructured":"Konijnenbelt-Peters J, van der Heijden C, Ekhart C, Bos J, Bruhn J, Kramers C (2017) Metamizole (dipyrone) as an alternative agent in postoperative analgesia in patients with contraindications for nonsteroidal anti-inflammatory drugs. Pain Pract 17:402\u2013408. https:\/\/doi.org\/10.1111\/papr.12467","journal-title":"Pain Pract"},{"key":"5470_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3344\/kjp.2018.31.3.174","volume":"31","author":"R Kooshki","year":"2018","unstructured":"Kooshki R, Abbasnejad M, Esmaeili Mahani S, Raoof M, Moeini Aghtaei MM, Dabiri S (2018) Orexin-a inhibits capsaicin-induced changes in cyclooxygenase-2 and brain-derived neurotrophic factor expression in trigeminal nucleus caudalis of rats. Korean J Pain 31:174\u2013182. https:\/\/doi.org\/10.3344\/kjp.2018.31.3.174","journal-title":"Korean J Pain"},{"key":"5470_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40120-018-0111-2","volume":"7","author":"C Lawthom","year":"2018","unstructured":"Lawthom C, Peltola J, McMurray R, Dodd E, Villanueva V (2018) Dibenzazepine agents in epilepsy: how does eslicarbazepine acetate differ? Neurol Ther 7:195\u2013206. https:\/\/doi.org\/10.1007\/s40120-018-0111-2","journal-title":"Neurol Ther"},{"key":"5470_CR31","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1073\/pnas.0306147101","volume":"101","author":"D Levy","year":"2004","unstructured":"Levy D, Jakubowski M, Burstein R (2004) Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B\/1D receptor agonists. Proc Natl Acad Sci U S A 101:4274\u20134279. https:\/\/doi.org\/10.1073\/pnas.0306147101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5470_CR32","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jpain.2006.04.010","volume":"7","author":"P Luccarini","year":"2006","unstructured":"Luccarini P, Childeric A, Gaydier AM, Voisin D, Dallel R (2006) The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. J Pain 7:908\u2013914. https:\/\/doi.org\/10.1016\/j.jpain.2006.04.010","journal-title":"J Pain"},{"key":"5470_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.pain.2008.03.030","volume":"139","author":"C Mallet","year":"2008","unstructured":"Mallet C, Daulhac L, Bonnefont J, Ledent C, Etienne M, Chapuy E, Libert F, Eschalier A (2008) Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain 139:190\u2013200. https:\/\/doi.org\/10.1016\/j.pain.2008.03.030","journal-title":"Pain"},{"key":"5470_CR34","first-page":"207","volume-title":"Pain relief: from analgesics to alternative therapies","author":"C Mallet","year":"2017","unstructured":"Mallet C, Eschalier A, Daulhac L (2017) Paracetamol: update on its analgesic mechanism of action. In: Maldonado C (ed) Pain relief: from analgesics to alternative therapies. InTech, Rijeka, pp 207\u2013224"},{"key":"5470_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/sj.bjp.0704599","volume":"135","author":"HF Miranda","year":"2002","unstructured":"Miranda HF, Sierralta F, Pinardi G (2002) Neostigmine interactions with non steroidal anti-inflammatory drugs. Br J Pharmacol 135:1591\u20131597. https:\/\/doi.org\/10.1038\/sj.bjp.0704599","journal-title":"Br J Pharmacol"},{"key":"5470_CR36","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1111\/bph.13129","volume":"172","author":"R Nassini","year":"2015","unstructured":"Nassini R, Fusi C, Materazzi S, Coppi E, Tuccinardi T, Marone IM, De Logu F, Preti D, Tonello R, Chiarugi A, Patacchini R, Geppetti P, Benemei S (2015) The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives. Br J Pharmacol 172:3397\u20133411. https:\/\/doi.org\/10.1111\/bph.13129","journal-title":"Br J Pharmacol"},{"key":"5470_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.neulet.2004.06.017","volume":"367","author":"K Okamoto","year":"2004","unstructured":"Okamoto K, Imbe H, Tashiro A, Kumabe S, Senba E (2004) Blockade of peripheral 5HT3 receptor attenuates the formalin-induced nocifensive behaviour in persistent temporomandibular joint inflammation of rat. Neurosci Lett 367:259\u2013263. https:\/\/doi.org\/10.1016\/j.neulet.2004.06.017","journal-title":"Neurosci Lett"},{"key":"5470_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.neuroscience.2005.06.032","volume":"135","author":"K Okamoto","year":"2005","unstructured":"Okamoto K, Kimura A, Donishi T, Imbe H, Senba E, Tamai Y (2005) Central serotonin 3 receptors play an important role in the modulation of nociceptive neural activity of trigeminal subnucleus caudalis and nocifensive orofacial behaviour in rats with persistent temporomandibular joint inflammation. Neuroscience 135:569\u2013581. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.06.032","journal-title":"Neuroscience"},{"key":"5470_CR39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuroscience.2006.08.009","volume":"143","author":"K Okamoto","year":"2006","unstructured":"Okamoto K, Kimura A, Donishi T, Imbe H, Nishie Y, Matsushita H, Tamai Y, Senba E (2006) Contribution of peripheral 5-HT2A or 5-HT3 receptors to Fos expression in the trigeminal spinal nucleus produced by acute injury to the masseter muscle during persistent temporomandibular joint inflammation in rats. Neuroscience 143:597\u2013606. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.08.009","journal-title":"Neuroscience"},{"key":"5470_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(83)90369-2","volume":"91","author":"HR Olpe","year":"1983","unstructured":"Olpe HR, Jones RS (1983) The action of anticonvulsant drugs on the firing of locus coeruleus neurons: selective, activating effect of carbamazepine. Eur J Pharmacol 91:107\u2013110. https:\/\/doi.org\/10.1016\/0014-2999(83)90369-2","journal-title":"Eur J Pharmacol"},{"key":"5470_CR41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","volume":"15","author":"JJY Ong","year":"2018","unstructured":"Ong JJY, De Felice M (2018) Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics 15:274\u2013290. https:\/\/doi.org\/10.1007\/s13311-017-0592-1","journal-title":"Neurotherapeutics"},{"key":"5470_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/head.12835","volume":"56","author":"SL Orr","year":"2016","unstructured":"Orr SL, Friedman BW, Christie S, Minen MT, Bamford C, Kelley NE, Tepper D (2016) Management of adults with acute migraine in the emergency department: the American headache society evidence assessment of parenteral pharmacotherapies. Headache 56:911\u2013940. https:\/\/doi.org\/10.1111\/head.12835","journal-title":"Headache"},{"key":"5470_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2018.10.059","volume":"214","author":"U Pecikoza","year":"2018","unstructured":"Pecikoza U, Micov A, Tomi\u0107 M, Stepanovi\u0107-Petrovi\u0107 R (2018a) Eslicarbazepine acetate reduces trigeminal nociception: possible role of adrenergic, cholinergic and opioid receptors. Life Sci 214:167\u2013175. https:\/\/doi.org\/10.1016\/j.lfs.2018.10.059","journal-title":"Life Sci"},{"key":"5470_CR44","first-page":"678","volume":"68","author":"U Pecikoza","year":"2018","unstructured":"Pecikoza U, Tomi\u0107 M, Micov A, Stepanovi\u0107-Petrovi\u0107 R (2018b) The local peripheral analgesic effect of eslicarbazepine acetate in a trigeminal pain model: the role of serotonin 5-HT1B\/1D and cannabinoid CB1\/CB2 receptors. Arh farm 68:678\u2013679","journal-title":"Arh farm"},{"key":"5470_CR45","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/ejp.1192","volume":"22","author":"A Sanchez-Larsen","year":"2018","unstructured":"Sanchez-Larsen A, Sopelana D, Diaz-Maroto I, Perona-Moratalla AB, Gracia-Gil J, Garc\u00eda-Mu\u00f1ozguren S, Palaz\u00f3n-Garc\u00eda E, Segura T (2018) Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia. Eur J Pain 22:1080\u20131087. https:\/\/doi.org\/10.1002\/ejp.1192","journal-title":"Eur J Pain"},{"key":"5470_CR46","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3389\/fphar.2018.00913","volume":"9","author":"GJ Sanger","year":"2018","unstructured":"Sanger GJ, Andrews PLR (2018) A history of drug discovery for treatment of nausea and vomiting and the implications for future research. Front Pharmacol 9:913. https:\/\/doi.org\/10.3389\/fphar.2018.00913","journal-title":"Front Pharmacol"},{"key":"5470_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3727\/000000003783992982","volume":"7","author":"J Sawynok","year":"2003","unstructured":"Sawynok J, Liu XJ (2003) The formalin test: characteristics and usefulness of the model. Rev Analg 7:145\u2013163. https:\/\/doi.org\/10.3727\/000000003783992982","journal-title":"Rev Analg"},{"key":"5470_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/10454411000110010401","volume":"11","author":"BJ Sessle","year":"2000","unstructured":"Sessle BJ (2000) Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 11:57\u201391. https:\/\/doi.org\/10.1177\/10454411000110010401","journal-title":"Crit Rev Oral Biol Med"},{"key":"5470_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/B978-0-12-385198-7.00007-2","volume":"97","author":"BJ Sessle","year":"2011","unstructured":"Sessle BJ (2011) Peripheral and central mechanisms of orofacial inflammatory pain. Int Rev Neurobiol 97:179\u2013206. https:\/\/doi.org\/10.1016\/B978-0-12-385198-7.00007-2","journal-title":"Int Rev Neurobiol"},{"key":"5470_CR50","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s40265-016-0570-7","volume":"76","author":"M Shirley","year":"2016","unstructured":"Shirley M, Dhillon S (2016) Eslicarbazepine acetate monotherapy: a review in partial-onset seizures. Drugs 76:707\u2013717. https:\/\/doi.org\/10.1007\/s40265-016-0570-7","journal-title":"Drugs"},{"key":"5470_CR51","doi-asserted-by":"publisher","first-page":"e00124","DOI":"10.1002\/prp2.124","volume":"3","author":"P Soares-da-Silva","year":"2015","unstructured":"Soares-da-Silva P, Pires N, Bonif\u00e1cio MJ, Loureiro AI, Palma N, Wright LC (2015) Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action. Pharmacol Res Perspect 3:e00124. https:\/\/doi.org\/10.1002\/prp2.124","journal-title":"Pharmacol Res Perspect"},{"key":"5470_CR52","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.pbb.2010.11.007","volume":"97","author":"RM Stepanovi\u0107-Petrovi\u0107","year":"2011","unstructured":"Stepanovi\u0107-Petrovi\u0107 RM, Tomi\u0107 MA, Vu\u010dkovi\u0107 SM, Poznanovi\u0107 G, Ugre\u0161i\u0107 ND, Prostran M\u0160, Bo\u0161kovi\u0107 B (2011) Pharmacological interaction between oxcarbazepine and two COX inhibitors in a rat model of inflammatory hyperalgesia. Pharmacol Biochem Behav 97:611\u2013618. https:\/\/doi.org\/10.1016\/j.pbb.2010.11.007","journal-title":"Pharmacol Biochem Behav"},{"key":"5470_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2377-11-43","volume":"11","author":"A Straube","year":"2011","unstructured":"Straube A, Aicher B, Fiebich BL, Haag G (2011) Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics? BMC Neurol 11:43. https:\/\/doi.org\/10.1186\/1471-2377-11-43","journal-title":"BMC Neurol"},{"key":"5470_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12950-018-0200-0","volume":"15","author":"Y Syoji","year":"2018","unstructured":"Syoji Y, Kobayashi R, Miyamura N, Hirohara T, Kubota Y, Uotsu N, Yui K, Shimazu Y, Takeda M (2018) Suppression of hyperexcitability of trigeminal nociceptive neurons associated with inflammatory hyperalgesia following systemic administration of lutein via inhibition of cyclooxygenase-2 cascade signaling. J Inflamm (Lond) 15:24. https:\/\/doi.org\/10.1186\/s12950-018-0200-0","journal-title":"J Inflamm (Lond)"},{"key":"5470_CR55","doi-asserted-by":"publisher","DOI":"10.1201\/9781420036107","volume-title":"Drug synergism and dose-effect data analysis","author":"RJ Tallarida","year":"2000","unstructured":"Tallarida RJ (2000) Drug synergism and dose-effect data analysis, 1st edn. Chapman & Hall\/CRC, Boca Raton","edition":"1"},{"key":"5470_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","volume":"98","author":"RJ Tallarida","year":"2002","unstructured":"Tallarida RJ (2002) The interaction index: a measure of drug synergism. Pain 98:163\u2013168. https:\/\/doi.org\/10.1016\/S0304-3959(02)00041-6","journal-title":"Pain"},{"key":"5470_CR57","doi-asserted-by":"publisher","first-page":"PL 417","DOI":"10.1016\/S0024-3205(97)01030-8","volume":"61","author":"RJ Tallarida","year":"1997","unstructured":"Tallarida RJ, Stone DJ Jr, Raffa RB (1997) Efficient designs for studying synergistic drug combinations. Life Sci 61:PL 417\u2013PL 425. https:\/\/doi.org\/10.1016\/S0024-3205(97)01030-8","journal-title":"Life Sci"},{"key":"5470_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0014-2999(91)90036-p","volume":"193","author":"A Tj\u00f8lsen","year":"1991","unstructured":"Tj\u00f8lsen A, Lund A, Hole K (1991) Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol 193:193\u2013201. https:\/\/doi.org\/10.1016\/0014-2999(91)90036-p","journal-title":"Eur J Pharmacol"},{"key":"5470_CR59","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1213\/ANE.0b013e3181cbd8da","volume":"110","author":"MA Tomi\u0107","year":"2010","unstructured":"Tomi\u0107 MA, Vu\u010dkovi\u0107 SM, Stepanovi\u0107-Petrovi\u0107 RM, Ugre\u0161i\u0107 ND, Prostran M\u0160, Bo\u0161kovi\u0107 B (2010) Synergistic interactions between paracetamol and oxcarbazepine in somatic and visceral pain models in rodents. Anesth Analg 110:1198\u20131205. https:\/\/doi.org\/10.1213\/ANE.0b013e3181cbd8da","journal-title":"Anesth Analg"},{"key":"5470_CR60","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jpain.2013.06.003","volume":"14","author":"MA Tomi\u0107","year":"2013","unstructured":"Tomi\u0107 MA, Micov AM, Stepanovi\u0107-Petrovi\u0107 RM (2013) Levetiracetam interacts synergistically with nonsteroidal analgesics and caffeine to produce antihyperalgesia in rats. J Pain 14:1371\u20131382. https:\/\/doi.org\/10.1016\/j.jpain.2013.06.003","journal-title":"J Pain"},{"key":"5470_CR61","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1213\/ANE.0000000000000953","volume":"121","author":"MA Tomi\u0107","year":"2015","unstructured":"Tomi\u0107 MA, Pecikoza UB, Micov AM, Stepanovi\u0107-Petrovi\u0107 RM (2015) The efficacy of eslicarbazepine acetate in models of trigeminal, neuropathic, and visceral pain: the involvement of 5-HT1B\/1D serotonergic and CB1\/CB2 cannabinoid receptors. Anesth Analg 121:1632\u20131639. https:\/\/doi.org\/10.1213\/ANE.0000000000000953","journal-title":"Anesth Analg"},{"key":"5470_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pharmthera.2018.06.002","volume":"192","author":"M Tomi\u0107","year":"2018","unstructured":"Tomi\u0107 M, Pecikoza U, Micov A, Vu\u010dkovi\u0107 S, Stepanovi\u0107-Petrovi\u0107 R (2018) Antiepileptic drugs as analgesics\/adjuvants in inflammatory pain: current preclinical evidence. Pharmacol Ther 192:42\u201364. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.06.002","journal-title":"Pharmacol Ther"},{"key":"5470_CR63","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.brainres.2005.04.083","volume":"1048","author":"E Vazquez","year":"2005","unstructured":"Vazquez E, Hernandez N, Escobar W, Vanegas H (2005) Antinociception induced by intravenous dipyrone (metamizol) upon dorsal horn neurons: involvement of endogenous opioids at the periaqueductal gray matter, the nucleus raphe magnus, and the spinal cord in rats. Brain Res 1048:211\u2013217. https:\/\/doi.org\/10.1016\/j.brainres.2005.04.083","journal-title":"Brain Res"},{"key":"5470_CR64","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00228-014-1734-6","volume":"70","author":"M Wehling","year":"2014","unstructured":"Wehling M (2014) Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects. Eur J Clin Pharmacol 70:1159\u20131172. https:\/\/doi.org\/10.1007\/s00228-014-1734-6","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-020-05470-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:11:11Z","timestamp":1612397471000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-020-05470-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5470"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05470-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2020,2,5]]},"assertion":[{"value":"12 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the Faculty of Pharmacy in Belgrade and ethical approval was obtained from the Institutional Animal Care and Use Committee of the Faculty of Pharmacy in Belgrade (permit number: 323-07-03984\/2017-05).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}